Celsius Holdings offers a buying opportunity despite the stock drop, with strong growth prospects in the health and wellness ...

See our analysis of Advanced Micro Devices Earnings Preview for a closer look at what to expect when the company publishes ...

Ocular Therapeutix's Elutyx drug delivery platform offers sustained long-term effects. See why OCUL stock is a Buy.

As an investor, mistakes are inevitable. But really bad investments should be rare. So take a moment to sympathize ...

DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

We rate Largan Precision’s Morningstar Capital Allocation Rating as Standard mainly due to the company’s underinvestment amid a cash-rich balance sheet. While the company’s management has grown the ...

World shares are higher after China's central bank released plans for supporting stock markets through share repurchases.

More than 40 S&P 500 companies are set to report results this week, including Netflix, Morgan Stanley, and Goldman Sachs.

The S&P 500 is on track to report 7% year-per-year earnings growth for the third quarter, according to estimates from FactSet ...

A new study suggests that standing for over two hours a day doesn't reduce cardiovascular risks and could increase the risk ...

Khanna and other prominent investors such as Rekha Jhunjhunwala expect mineral stocks to thrive in 2025. Will their bets pay ...